The study found that semaglutide resulted in significant weight loss until week 60, with the effects maintained through week 104
Contraindications Include: Copper metabolism disorders Severe liver disease Certain chronic medical conditions Pregnancy or breastfeeding unless medically approved A full medical consultation helps determine whether peptide therapy is appropriate for your health profile
Both Zepbound and Retatrutide belong to a class of medications called incretin mimeticssynthetic compounds that mimic the natural hormones your gut secretes when you eat food
Ferraro F, Lymperi S, Mndez-Ferrer S, Saez B, Spencer JA, Yeap BY, Masselli E, Graiani G, Prezioso L, Rizzini EL, Mangoni M, Rizzoli V, Sykes SM, Lin CP, Frenette PS, Quaini F, Scadden DT
For details about brand-name options, please consult your licensed healthcare provider or pharmacist